Terms: = Pancreatic cancer AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1 AND Treatment
30 results:
1. Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian cancer.
Lou E; Clemente V; Grube M; Svedbom A; Nelson AC; Blome F; Staebler A; Kommoss S; Bazzaro M
JAMA Netw Open; 2024 Feb; 7(2):e240407. PubMed ID: 38411963
[TBL] [Abstract] [Full Text] [Related]
2. NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic pancreatic cancer: A Systematic Review and Meta-Analysis.
Nichetti F; Rota S; Ambrosini P; Pircher C; Gusmaroli E; Droz Dit Busset M; Pusceddu S; Sposito C; Coppa J; Morano F; Pietrantonio F; Di Bartolomeo M; Mariani L; Mazzaferro V; de Braud F; Niger M
JAMA Netw Open; 2024 Jan; 7(1):e2350756. PubMed ID: 38190183
[TBL] [Abstract] [Full Text] [Related]
3. Combination of runx1 inhibitor and gemcitabine mitigates chemo-resistance in pancreatic ductal adenocarcinoma by modulating BiP/PERK/eIF2α-axis-mediated endoplasmic reticulum stress.
She C; Wu C; Guo W; Xie Y; Li S; Liu W; Xu C; Li H; Cao P; Yang Y; Wang X; Chang A; Feng Y; Hao J
J Exp Clin Cancer Res; 2023 Sep; 42(1):238. PubMed ID: 37697370
[TBL] [Abstract] [Full Text] [Related]
4. cancer survival analysis and spatial distribution during 2014-2016 in Shandong Province, China.
Jiang F; Fu Z; Lu Z; Chu J; Xu A; Guo X; Ma J
Sci Rep; 2023 Jun; 13(1):10324. PubMed ID: 37365230
[TBL] [Abstract] [Full Text] [Related]
5. Systemic therapy with or without transcatheter intra-arterial therapies for unresectable hepatocellular carcinoma: a real-world, multi-center study.
Pan Y; Zhu X; Liu J; Zhong J; Zhang W; Shen S; Jin R; Liu H; Ye F; Hu K; Xu D; Zhang Y; Chen Z; Xing B; Zhou L; Chen Y; Zeng Y; Liang X; Kuang M; Song T; Xiang B; Wang K; Sun H; Xu L;
Front Immunol; 2023; 14():1138355. PubMed ID: 37180173
[TBL] [Abstract] [Full Text] [Related]
6. Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia.
Wang Q; Cai WZ; Wang QR; Zhu MQ; Yan LZ; Yu Y; Bao XB; Shen HJ; Yao H; Xie JD; Zhang TT; Zhang L; Xu XY; Shan Z; Liu H; Cen JN; Liu DD; Pan JL; Lu DR; Chen J; Xu Y; Zhang R; Wang Y; Xue SL; Miao M; Han Y; Tang XW; Qiu HY; Sun AN; Huang JY; Dai HP; Wu DP; Chen SN
Am J Hematol; 2023 Jan; 98(1):66-78. PubMed ID: 36219502
[TBL] [Abstract] [Full Text] [Related]
7. NOXA expression drives synthetic lethality to runx1 inhibition in pancreatic cancer.
Doffo J; Bamopoulos SA; Köse H; Orben F; Zang C; Pons M; den Dekker AT; Brouwer RWW; Baluapuri A; Habringer S; Reichert M; Illendula A; Krämer OH; Schick M; Wolf E; van IJcken WFJ; Esposito I; Keller U; Schneider G; Wirth M
Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35197278
[TBL] [Abstract] [Full Text] [Related]
8. Dosimetry impact of gating latency in cine magnetic resonance image guided breath-hold pancreatic cancer radiotherapy.
Hu P; Li X; Liu W; Yan B; Xue X; Yang F; Ford JC; Portelance L; Yang Y
Phys Med Biol; 2022 Feb; 67(5):. PubMed ID: 35144247
[No Abstract] [Full Text] [Related]
9. Blocking hepatocarcinogenesis by a cytochrome P450 family member with female-preferential expression.
Ji F; Zhang J; Liu N; Gu Y; Zhang Y; Huang P; Zhang N; Lin S; Pan R; Meng Z; Feng XH; Roessler S; Zheng X; Ji J
Gut; 2022 Nov; 71(11):2313-2324. PubMed ID: 34996827
[TBL] [Abstract] [Full Text] [Related]
10. Using a Nomogram to Preoperatively Predict Distant Metastasis of pancreatic Neuroendocrine Tumor in Elderly Patients.
Li G; Bing YT; Tian ML; Yuan CH; Xiu DR
Chin Med Sci J; 2021 Sep; 36(3):218-224. PubMed ID: 34666875
[TBL] [Abstract] [Full Text] [Related]
11. The clinicopathologic and operative characteristics of patients with small nonfunctioning pancreatic neuroendocrine tumors.
Ha S; Song KB; Hong S; Shin D; Park Y; Kwon J; Lee W; Jun E; Lee JH; Hwang DW; Kim SC
ANZ J Surg; 2021 Jul; 91(7-8):E484-E492. PubMed ID: 34291544
[TBL] [Abstract] [Full Text] [Related]
12. Relationships are between metformin use and survival in pancreatic cancer patients concurrent with diabetes: A systematic review and meta-analysis.
Shi YQ; Zhou XC; Du P; Yin MY; Xu L; Chen WJ; Xu CF
Medicine (Baltimore); 2020 Sep; 99(37):e21687. PubMed ID: 32925714
[TBL] [Abstract] [Full Text] [Related]
13. Nomogram for Estimating Overall Survival in Patients With Metastatic pancreatic cancer.
Goldstein D; Von Hoff DD; Chiorean EG; Reni M; Tabernero J; Ramanathan RK; Botteman M; Aly A; Margunato-Debay S; Lu B; Louis CU; McGovern D; Lee CK
Pancreas; 2020 Jul; 49(6):744-750. PubMed ID: 32541630
[TBL] [Abstract] [Full Text] [Related]
14. Outcomes of patients with initially locally advanced pancreatic adenocarcinoma who did not benefit from resection: a prospective cohort study.
Garnier J; Ewald J; Marchese U; Gilabert M; Launay S; Moureau-Zabotto L; Poizat F; Giovannini M; Delpero JR; Turrini O
BMC Cancer; 2020 Mar; 20(1):203. PubMed ID: 32164564
[TBL] [Abstract] [Full Text] [Related]
15. Estimates of Overall Survival in Patients With cancer Receiving Different treatment Regimens: Emulating Hypothetical Target Trials in the Surveillance, Epidemiology, and End Results (SEER)-Medicare Linked Database.
Petito LC; García-Albéniz X; Logan RW; Howlader N; Mariotto AB; Dahabreh IJ; Hernán MA
JAMA Netw Open; 2020 Mar; 3(3):e200452. PubMed ID: 32134464
[TBL] [Abstract] [Full Text] [Related]
16. The Benefit-Risk Balance of Nab-Paclitaxel in Metastatic pancreatic Adenocarcinoma.
Péron J; Giai J; Maucort-Boulch D; Buyse M
Pancreas; 2019 Feb; 48(2):275-280. PubMed ID: 30629024
[TBL] [Abstract] [Full Text] [Related]
17. High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National cancer Database Study.
Alese OB; Jiang R; Shaib W; Wu C; Akce M; Behera M; El-Rayes BF
Oncologist; 2019 Jul; 24(7):911-920. PubMed ID: 30482824
[TBL] [Abstract] [Full Text] [Related]
18. Laparoscopic duodenum-preserving total pancreatic head resection: a novel surgical approach for benign or low-grade malignant tumors.
Cao J; Li GL; Wei JX; Yang WB; Shang CZ; Chen YJ; Lau WY; Min J
Surg Endosc; 2019 Feb; 33(2):633-638. PubMed ID: 30456509
[TBL] [Abstract] [Full Text] [Related]
19. Isolated pancreatic Myeloid Sarcoma Associated with t(8;21)/runx1-runx1T1 Rearrangement.
Tokunaga K; Yamamura A; Ueno S; Kikukawa Y; Yamaguchi S; Hidaka M; Matsuno N; Kawaguchi T; Matsuoka M; Okuno Y
Intern Med; 2018 Feb; 57(4):563-568. PubMed ID: 29151502
[TBL] [Abstract] [Full Text] [Related]
20. RN1, a novel galectin-3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivo via blocking galectin-3 associated signaling pathways.
Zhang L; Wang P; Qin Y; Cong Q; Shao C; Du Z; Ni X; Li P; Ding K
Oncogene; 2017 Mar; 36(9):1297-1308. PubMed ID: 27617577
[TBL] [Abstract] [Full Text] [Related]
[Next]
